Ansh Therapeutics Private Limited, a active private limited company, was established on 24 June 2010 in New Delhi, Delhi, India. Engaging in medical equipment retail & distribution within the trade sector, it holds CIN: U33110DL2010PTC204655. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Sandeep Bajaj (Director), Harpreet Bajaj (Director). It holds ₹3.25 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 220/1, First Floor Nangal Raya, New Delhi, Delhi, 110046.
U33110DL2010PTC204655
204655
24 June 2010
₹1.00 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Ansh Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandeep Bajaj | Director | 24 Jun 2010 | Current |
| Harpreet Bajaj | Director | 24 Jun 2010 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ansh Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 152.35% increase. The company also saw a substantial improvement in profitability, with a 220.4% increase in profit. The company's net worth Soared by an impressive increase of 76.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Ansh Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹32,490,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Aug 2024 | Others | ₹2.50 Cr | Open |
| 30 Aug 2021 | Hdfc Bank Limited | ₹7.49 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ansh Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ansh Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ansh Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ansh Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 25.00 M with Charge ID 100967275 was registered on 15 Aug 2024. was completed.
The activity Ansh Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 7.49 M with Charge ID 100491770 was registered on 30 Aug 2021. was recorded as a recent event.
Progress on Sandeep Bajaj was appointed as a Director was appointed as a Director on 24 Jun 2010 & has been associated with this company since 15 years 5 months . was documented.
Progress on Harpreet Bajaj was appointed as a Director was appointed as a Director on 24 Jun 2010 & has been associated with this company since 15 years 5 months . was documented.
The CIN of Ansh Therapeutics Private Limited is U33110DL2010PTC204655.
Ansh Therapeutics Private Limited is headquartered at 220/1, First Floor Nangal Raya, New Delhi, Delhi, 110046.
Ansh Therapeutics Private Limited was incorporated on 24 June 2010.
The current directors of Ansh Therapeutics Private Limited are
The primary industry of Ansh Therapeutics Private Limited is Trade.
Ansh Therapeutics Private Limited is unlisted.
The authorized capital of Ansh Therapeutics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Ansh Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX